• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生成药物性胆汁淤积、脂肪变性、肝炎和肝硬化生物网络的半自动方法。

Semi-automated approach for generation of biological networks on drug-induced cholestasis, steatosis, hepatitis, and cirrhosis.

作者信息

Shin Hyun Kil, Florean Oana, Hardy Barry, Doktorova Tatyana, Kang Myung-Gyun

机构信息

Toxicoinformatics Group, Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114 Republic of Korea.

Human and Environmental Toxicology, University of Science and Technology, Daejeon, 34113 Republic of Korea.

出版信息

Toxicol Res. 2022 Mar 3;38(3):393-407. doi: 10.1007/s43188-022-00124-6. eCollection 2022 Jul.

DOI:10.1007/s43188-022-00124-6
PMID:35865277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9247124/
Abstract

UNLABELLED

Drug-induced liver injury (DILI) is one of the leading reasons for discontinuation of a new drug development project. Diverse machine learning or deep learning models have been developed to predict DILI. However, these models have not provided an adequate understanding of the mechanisms leading to DILI. The development of safer drugs requires novel computational approaches that enable the prompt understanding of the mechanism of DILI. In this study, the mechanisms leading to the development of cholestasis, steatosis, hepatitis, and cirrhosis were explored using a semi-automated approach for data gathering and associations. Diverse data from ToxCast, Comparative Toxicogenomic Database (CTD), Reactome, and Open TG-GATEs on reference molecules leading to the development of the respective diseases were extracted. The data were used to create biological networks of the four diseases. As expected, the four networks had several common pathways, and a joint DILI network was assembled. Such biological networks could be used in drug discovery to identify possible molecules of concern as they provide a better understanding of the disease-specific key events. The events can be target-tested to provide indications for potential DILI effects.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s43188-022-00124-6.

摘要

未标注

药物性肝损伤(DILI)是新药研发项目终止的主要原因之一。已经开发了多种机器学习或深度学习模型来预测DILI。然而,这些模型尚未充分理解导致DILI的机制。开发更安全的药物需要新颖的计算方法,以便能够迅速理解DILI的机制。在本研究中,使用半自动数据收集和关联方法探索了导致胆汁淤积、脂肪变性、肝炎和肝硬化的机制。从ToxCast、比较毒理基因组数据库(CTD)、Reactome和Open TG-GATEs中提取了与导致各自疾病发展的参考分子相关的各种数据。这些数据用于创建四种疾病的生物网络。正如预期的那样,这四个网络有几个共同的途径,并组装了一个联合DILI网络。这种生物网络可用于药物发现,以识别可能令人关注的分子,因为它们能更好地理解疾病特异性关键事件。可以对这些事件进行靶点测试,以提供潜在DILI效应的指示。

补充信息

在线版本包含可在10.1007/s43188-022-00124-6获取的补充材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/f00b0e33e5a9/43188_2022_124_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/a45b98148f0c/43188_2022_124_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/87d4b5e56a73/43188_2022_124_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/e9b7a284d8d5/43188_2022_124_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/a0ff266b86b0/43188_2022_124_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/205209a583fd/43188_2022_124_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/78a3465614b3/43188_2022_124_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/dfe55ecb5fcf/43188_2022_124_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/6ee9cba085eb/43188_2022_124_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/f00b0e33e5a9/43188_2022_124_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/a45b98148f0c/43188_2022_124_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/87d4b5e56a73/43188_2022_124_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/e9b7a284d8d5/43188_2022_124_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/a0ff266b86b0/43188_2022_124_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/205209a583fd/43188_2022_124_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/78a3465614b3/43188_2022_124_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/dfe55ecb5fcf/43188_2022_124_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/6ee9cba085eb/43188_2022_124_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4f/9247124/f00b0e33e5a9/43188_2022_124_Fig9_HTML.jpg

相似文献

1
Semi-automated approach for generation of biological networks on drug-induced cholestasis, steatosis, hepatitis, and cirrhosis.用于生成药物性胆汁淤积、脂肪变性、肝炎和肝硬化生物网络的半自动方法。
Toxicol Res. 2022 Mar 3;38(3):393-407. doi: 10.1007/s43188-022-00124-6. eCollection 2022 Jul.
2
Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures.基于药物和药物代谢物结构的药物性胆汁淤积、肝硬化、肝炎和脂肪变性预测模型的开发。
Front Pharmacol. 2020 Feb 14;11:67. doi: 10.3389/fphar.2020.00067. eCollection 2020.
3
ToxSTAR: drug-induced liver injury prediction tool for the web environment.ToxSTAR:用于网络环境的药物性肝损伤预测工具。
Bioinformatics. 2022 Sep 15;38(18):4426-4427. doi: 10.1093/bioinformatics/btac490.
4
In-silico approach for drug induced liver injury prediction: Recent advances.计算机辅助药物性肝损伤预测方法:最新进展。
Toxicol Lett. 2018 Oct 1;295:288-295. doi: 10.1016/j.toxlet.2018.06.1216. Epub 2018 Jul 5.
5
Insights into mechanisms and severity of drug-induced liver injury via computational systems toxicology approach.通过计算系统毒理学方法洞察药物性肝损伤的机制和严重程度。
Toxicol Lett. 2019 Sep 15;312:22-33. doi: 10.1016/j.toxlet.2019.05.005. Epub 2019 May 4.
6
Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).比较用于预测药物性肝损伤(DILI)的机器学习算法。
Mol Pharm. 2020 Jul 6;17(7):2628-2637. doi: 10.1021/acs.molpharmaceut.0c00326. Epub 2020 Jun 8.
7
New finding based on Comparative Toxicogenomics Database: Hepatic YY1 mediates drug-induced liver injury.基于比较毒理学基因组学数据库的新发现:肝 YY1 介导药物性肝损伤。
Phytomedicine. 2024 Dec;135:156102. doi: 10.1016/j.phymed.2024.156102. Epub 2024 Sep 27.
8
Chemistry-Based Modeling on Phenotype-Based Drug-Induced Liver Injury Annotation: From Public to Proprietary Data.基于化学的表型药物性肝损伤标注建模:从公共数据到私有数据。
Chem Res Toxicol. 2023 Aug 21;36(8):1238-1247. doi: 10.1021/acs.chemrestox.2c00378. Epub 2023 Aug 9.
9
Development of a Battery of Prediction Tools for Drug-Induced Liver Injury from the Vantage Point of Translational Safety Assessment.从转化安全评估的角度开发用于药物性肝损伤预测的工具组合。
Chem Res Toxicol. 2021 Feb 15;34(2):601-615. doi: 10.1021/acs.chemrestox.0c00423. Epub 2020 Dec 23.
10
Prediction of drug induced liver injury using molecular and biological descriptors.利用分子和生物学描述符预测药物性肝损伤
Comb Chem High Throughput Screen. 2015;18(3):315-22. doi: 10.2174/1386207318666150305144650.

引用本文的文献

1
Refining Drug-Induced Cholestasis Prediction: An Explainable Consensus Model Integrating Chemical and Biological Fingerprints.优化药物性胆汁淤积预测:一种整合化学和生物指纹图谱的可解释性共识模型
J Chem Inf Model. 2025 Jun 9;65(11):5301-5316. doi: 10.1021/acs.jcim.4c02363. Epub 2025 May 27.
2
In silico modeling-based new alternative methods to predict drug and herb-induced liver injury: A review.基于计算机模拟的预测药物和草药肝损伤新替代方法的研究进展。
Food Chem Toxicol. 2023 Sep;179:113948. doi: 10.1016/j.fct.2023.113948. Epub 2023 Jul 17.
3
Loganin Prevents Hepatic Steatosis by Blocking NLRP3 Inflammasome Activation.

本文引用的文献

1
Stop Explaining Black Box Machine Learning Models for High Stakes Decisions and Use Interpretable Models Instead.停止为高风险决策解释黑箱机器学习模型,转而使用可解释模型。
Nat Mach Intell. 2019 May;1(5):206-215. doi: 10.1038/s42256-019-0048-x. Epub 2019 May 13.
2
Tox-GAN: An Artificial Intelligence Approach Alternative to Animal Studies-A Case Study With Toxicogenomics.毒理生成对抗网络:一种替代动物实验的人工智能方法——毒理基因组学案例研究
Toxicol Sci. 2022 Mar 28;186(2):242-259. doi: 10.1093/toxsci/kfab157.
3
Application of the adverse outcome pathway framework to predict the toxicity of chemicals in the semiconductor manufacturing industry.
马钱子苷通过阻断NLRP3炎性小体激活预防肝脂肪变性。
Biomol Ther (Seoul). 2023 Jan 1;31(1):40-47. doi: 10.4062/biomolther.2022.077. Epub 2022 Sep 16.
应用不良结局途径框架预测半导体制造业中化学物质的毒性。
Mol Cell Toxicol. 2021;17(3):325-345. doi: 10.1007/s13273-021-00139-4. Epub 2021 May 5.
4
The Promise of AI for DILI Prediction.人工智能用于药物性肝损伤预测的前景
Front Artif Intell. 2021 Apr 14;4:638410. doi: 10.3389/frai.2021.638410. eCollection 2021.
5
Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice.药物性肝损伤(DILI)中的氧化应激:从机制到临床实践中使用的生物标志物
Antioxidants (Basel). 2021 Mar 5;10(3):390. doi: 10.3390/antiox10030390.
6
A semi-automated workflow for adverse outcome pathway hypothesis generation: The use case of non-genotoxic induced hepatocellular carcinoma.半自动化不良结局通路假说生成工作流程:以非遗传毒性诱导肝细胞癌为例。
Regul Toxicol Pharmacol. 2020 Jul;114:104652. doi: 10.1016/j.yrtph.2020.104652. Epub 2020 Apr 3.
7
EGR1 Transcription Factor is a Multifaceted Regulator of Matrix Production in Tendons and Other Connective Tissues.EGR1 转录因子是肌腱和其他结缔组织中基质产生的多效调节剂。
Int J Mol Sci. 2020 Feb 28;21(5):1664. doi: 10.3390/ijms21051664.
8
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach?动物研究在预测临床试验中毒性方面的局限性:是时候重新思考我们当前的方法了吗?
JACC Basic Transl Sci. 2019 Nov 25;4(7):845-854. doi: 10.1016/j.jacbts.2019.10.008. eCollection 2019 Nov.
9
SGK1 activation exacerbates diet-induced obesity, metabolic syndrome and hypertension.SGK1 激活会加剧饮食诱导的肥胖、代谢综合征和高血压。
J Endocrinol. 2020 Jan;244(1):149-162. doi: 10.1530/JOE-19-0275.
10
Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice.肝星状细胞中脂蛋白脂肪酶上调加剧小鼠非酒精性脂肪性肝炎中的肝纤维化
Hepatol Commun. 2019 Jun 6;3(8):1098-1112. doi: 10.1002/hep4.1383. eCollection 2019 Aug.